What does Alcami do?
ALCAMI is a biopharmaceutical company that specializes in providing contract development and manufacturing services. It focuses on delivering high-quality solutions for drug development, including formulation, analytical testing, and sterile manufacturing. ALCAMI aims to support pharmaceutical clients in bringing their products to market efficiently and effectively.
- Sectors
- Consultancy firms Holding companies
- Activities
- Signals
-
ProfitableProfitable € 29K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 181.24MStrong equity provides a buffer against setbacks.
Low riskLow risk 94.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.84A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 10.49MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 29KPositive EBITDA: operating activities are profitable.
- Investments
- Sicorp 33,19%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
36K
|
€
45K
|
€
45K
|
€
70K
|
|
|
€
29K
|
€
39K
|
€
39K
|
€
67K
|
|
|
€
10.49M
|
€
15.12M
|
€
-79K
|
€
153K
|
|
|
€
181.24M
|
€
186.75M
|
€
171.63M
|
€
171.71M
|
|
|
94.34%
|
95.27%
|
94.52%
|
94.66%
|
|
|
€
10.87M
|
€
9.26M
|
€
9.95M
|
€
9.68M
|
|
|
€
18.97M
|
€
23.54M
|
€
9.24M
|
€
9.61M
|
Publications 2
All publicationsNews
Show all- Alcami Promotes Robert Tragas To Vice President Of Lab Services Contract Pharma 1 week ago
- Alcami Announces Promotion Of Robert Tragas To Vice President, Laboratory Services News-Medical 1 week ago
- Alcami Strengthens Commercial Operations With Appointment Of Will Isom Manufacturing Chemist 1 month ago
- Biologics Fill-Finish: Technical And Operational Aspects Of Tech Transfer And Scale-Up Contract Pharma 1 month ago
- Alcami Appoints Will Isom To Lead Laboratory Services Sales Pharmafile 1 month ago
Frequently asked questions
Answers to the most common questions about Alcami, based on official government data and the filed annual accounts.
What is the VAT number of Alcami?
The VAT number of Alcami is BE0740.591.634.
When was Alcami established?
Alcami was founded in 30-12-2019.
What is the official address of Alcami?
The official address of Alcami is Hagedoornlaan 15 Antwerpen 2610.
What is the legal form of Alcami?
The juridical form of Alcami is Private limited company (BV/SRL).
What is the annual revenue of Alcami?
The 2025 accounts of Alcami do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Alcami do?
ALCAMI is a biopharmaceutical company that specializes in providing contract development and manufacturing services. It focuses on delivering high-quality solutions for drug development, including formulation, analytical testing, and sterile manufacturing. ALCAMI aims to support pharmaceutical clients in bringing their products to market efficiently and effectively.
Is Alcami a reliable company?
Alcami is a registered Rechtspersoon with company number 0740.591.634 and can be verified through the official CBE database.
What is the credit limit of Alcami?
The estimated credit limit of Alcami is €8,863,737.
Is Alcami still active?
Alcami currently has the status "Normal situation" and is active.